Research warns of lasting health impacts from muscle loss in young cancer patients

Research warns of lasting health impacts from muscle loss in young cancer patients

New research from the Exercise Medicine Research Institute at Edith Cowan University (ECU) has highlighted that children undergoing cancer treatment often lose skeletal muscle at a time when they should be rapidly gaining it, a loss that could increase treatment complications and raise the risk of long-term health problems.  Both the cancer itself and…

Read More
Glenmark launches generic cancer treatment drug in US

Glenmark launches generic cancer treatment drug in US

Glenmark Pharmaceuticals on Tuesday said it has launched a cancer treatment generic medication in the US market. Glenmark Pharmaceuticals Inc., USA, a subsidiary of the Mumbai-based drug firm, will launch Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials, it said in a statement. Glenmark’s product is therapeutically equivalent to the reference listed drug…

Read More